Advanced Clinical Blog listing page

By

Topics

Subscribe Here!

Cheryle Evans

Addressing E6(R2) as an SMB: Why small pharma and emerging biotechs may be falling behind

Clinical Research / Monitoring

Addressing E6(R2) as an SMB: Why small pharma and emerging biotechs may be falling behind
By Cheryle Evans on June 11, 2019

It’s been three years since ICH added the E6(R2) addendum to its Good Clinical Practice guidelines. The addendum was intended to create harmonization between US and EU clinical research...

Continue Reading

Stay up to date

© 2024 Advanced Clinical. All Rights Reserved

Terms & Conditions
|
Privacy Policy
|
Contact Us

© 2024 Advanced Clinical. All Rights Reserved

Terms & Conditions
Privacy Policy
Contact Us